BB Biotech AG
BION | SW
Overview
Corporate Details
- ISIN(s):
- CH0027659793 (+1 more)
- LEI:
- 391200MBZQNPFHIVKO34
- Country:
- Switzerland
- Address:
- Schwertstrasse 6, 8200 Schaffhausen
- Sector:
- Mining and quarrying
- Industry:
- Extraction of natural gas
Description
BB Biotech AG is a global investment company specializing in the biotechnology sector. With over 30 years of experience, it is one of the world's largest investors in this field. The company's strategy focuses on investing in publicly listed, fast-growing biotechnology firms that are developing and commercializing innovative drugs. Its portfolio targets companies whose products address significant unmet medical needs, thereby offering potential for above-average sales and profit growth. BB Biotech provides its shareholders with access to a diversified portfolio of high-growth potential companies within the biotech market.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for BB Biotech AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-25 07:00 |
Report Publication Announcement
BB Biotech AG publishes its interim report
|
English | 7.0 KB | |
| 2025-07-25 02:00 |
Earnings Release
EQS-News: BB Biotech Q2 2025: outperforms Nasdaq Biotech Index; strong USD retu…
|
English | 25.4 KB | |
| 2025-07-25 02:00 |
Earnings Release
EQS-News: BB Biotech Q2 2025: Outperformance zum Nasdaq Biotech Index – Starke …
|
German | 29.1 KB | |
| 2025-07-25 02:00 |
Report Publication Announcement
EQS-Adhoc: BB Biotech AG publishes its interim report
|
English | 5.3 KB | |
| 2025-07-25 02:00 |
Report Publication Announcement
EQS-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
|
German | 5.6 KB | |
| 2025-07-25 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 5.5 MB | |
| 2025-06-23 07:00 |
Major Shareholding Notification
|
English | 23.2 KB | |
| 2025-06-23 02:00 |
Declaration of Voting Results & Voting Rights Announcements
EQS-PVR: Disclosure of Shareholdings
|
English | 23.9 KB | |
| 2025-04-25 07:00 |
Report Publication Announcement
BB Biotech AG publishes its interim report
|
English | 6.5 KB | |
| 2025-04-25 00:00 |
Interim Report
Q1 statement / Q1 financial report 2025
|
English | 6.6 MB | |
| 2025-03-20 17:45 |
Post-Annual General Meeting Information
Shareholders at BB Biotech AGs AGM vote in favor of all proposals and approve t…
|
English | 6.4 KB | |
| 2025-03-19 17:45 |
Post-Annual General Meeting Information
Shareholders at BB Biotech AGs AGM vote in favor of all proposals and approve t…
|
English | 6.4 KB | |
| 2025-03-06 17:41 |
Director's Dealing
BB BIOTECH AG: Dr. Thomas von Planta, buy
|
English | 6.0 KB | |
| 2025-02-22 07:00 |
Report Publication Announcement
BB Biotech AG publishes its 2024 annual report
|
English | 7.7 KB | |
| 2025-02-21 07:00 |
Report Publication Announcement
BB Biotech AG publishes its 2024 annual report
|
English | 7.7 KB |
Automate Your Workflow. Get a real-time feed of all BB Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BB Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-05 | N/A | Non-Executive member | Buy | None | 40,893.80 CHF |
| 2024-09-16 | N/A | Non-Executive member | Buy | None | 47,103.20 CHF |
| 2024-07-29 | N/A | Non-Executive member | Buy | None | 54,913.50 CHF |
| 2024-04-30 | N/A | Non-Executive member | Buy | None | 41,450.00 CHF |
| 2024-03-25 | N/A | Non-Executive member | Buy | None | 55,167.50 CHF |
| 2024-03-22 | N/A | Non-Executive member | Buy | None | 105,927.16 CHF |
%20PLC/other/PARKMEAD_GROUP_THE_PLC-logo.png){kind=logo}
